WEDNESDAY, Sept. 18, 2024 -- Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH)...

TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...

TUESDAY, Oct. 1, 2024 -- For patients with acute myocardial infarction (MI) and anemia, 30-day risks for death or recurrent MI seem to increase with...

TUESDAY, Sept. 24, 2024 -- Nearly half of patients with cancer experience some level of financial hardship (FH), according to a study published...

WEDNESDAY, Sept. 18, 2024 -- Break Wave lithotripsy (BWL) is a safe and effective noninvasive stone therapy, according to a study published online...

TUESDAY, Oct. 1, 2024 -- Patients with fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest study...

MONDAY, Sept. 23, 2024 -- For patients with recurrent or refractory graft-versus-host disease (GVHD), the colony-stimulating factor 1 receptor...

TUESDAY, Oct. 1, 2024 -- Children with primary nocturnal enuresis may have vitamin D insufficiency and deficiency as well as vitamin B12 deficiency,...

TUESDAY, Sept. 24, 2024 -- For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first...

TUESDAY, Sept. 17, 2024 -- A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with...